TNFRSF9 and acute myeloid leukemia: We therefore compared the therapeutic efficacy of NKp30-CD28 and NKp30-CD137 CAR TCRKO T cells in vivo in an A375-melanoma NSG xenograft model with B7H6 expression levels similar to, e.g., AML samples MZ116, MZ201 and MZ612.